In the period between 1988-89, the company only manufactured penicillin. They have since then expanded into antibiotics, anti-allergic, antiretrovirals, cardiovascular, central nervous system ... Sep 21
The pharma stocks for long term wealth creation ... Jan 11
Top ten mid cap Indian pharma stocks , January 2021... Jan 07
Biocon subsidiary Mylan advances their ... Dec 14
... Dec 09
Penicillamine Tablets USP, 250 mg, are indicated in the treatment of Wilson’s disease, Cystinuria, and in patients with severe, active rheumatoid arthritis... Dec 01
A series of clinical trials will be conducted towards new and innovative solutions to manage COVID-19 pandemic in India as part of this collaboration... Sep 23
Receives ANDA for Lisinopril and Acylovir tablets... Sep 21
The Food and Drug Administration recommended Mylan Chief Executive Officer Heather Bresch hire a consultant to help the generic drugmaker improve its manufacturing practices... Sep 03
Biocon Biologics and Mylan announce launch of Semglee (insulin glargine injection) in the U.S. to expand access for patients living with diabetes ... Aug 31
The approval of Nepexto by the European Medicines Agency (EMA) underlines the scientific success of Lupin’s biosimilar programs... Aug 26
Nepal's Medical Council's directive (Interim Clinical Guidance for COVID-19) also has enlisted Remdesivir drug for the primary medication.... Aug 22
TB Alliance announces European commission authorisation of new treatment for highly drug-resistant tuberculosis ... Aug 04
Mylan will manufacture remdesivir in India and would sell at Rs4,800 which is 80% less than the price in developed countries... Jul 10
Cipla had earlier said pricing would not exceed 5,000 rupees. On Tuesday, Sovereign Pharma, which is manufacturing and packaging the drug for Cipla... Jul 09
Health Ministry drops Azithromycin, suggest HCQ and Remdesivir instead for COVID patients... Jun 15
Semglee is to be offered in vial and pen presentations... Jun 12
Reportedly, the PTAB also found Sanofi’s proposed amended claims for the ‘486 and ‘844 patents unpatentable.... Jun 02
Biocon Biologics receives EU GMP certification for multiple biosimilars manufacturing facilities in Bengaluru ... May 27
Under the licensing agreements, the companies have a right to receive a technology transfer of the Gilead Sciences manufacturing process for remdesivir to enable them ... May 13
The CHMP positive opinion will now be considered by the European Commission (EC). Once approved the EC will grant a centralized marketing authorization for member ... Mar 28
CEO of BIOCON confirmed "We are extremely pleased with the U.S. court ruling in favour of our Insulin Glargine device as this takes us ... Mar 12
Biocon and Mylan’s proposed biosimilar bevacizumab is expected to be the third biosimilar from the partnered portfolio for the cancer patients in the U.... Mar 12
True North to invest 536.24 crores in Biocon for 2.44% minority stake... Jan 07
... Sep 13
-Advertisements-
Thursday, April 25, 2024
